Skip to main content
Equibles

Ikarian Capital, LLC

Position in PRQR — ProQR Therapeutics N.V.

CIK 1778253 DALLAS, TX
Back to PRQR Full portfolio

Position in PRQR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,372,229
+$3,954,819 QoQ
Shares Held
3,425,930
+129.6% QoQ
Ownership
2.43%
of shares outstanding
% of Portfolio
1.03%
of 13F equity value
Holder Rank
#5
of 69 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PRQR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. PRQR ranks #29 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in PRQR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,372,229 3,425,930
2026-03-31 $2,417,410 1,492,229
2025-12-31 $3,014,302 1,492,229
2025-09-30 $1,900,447 892,229
2025-06-30 $1,770,860 868,069
2024-09-30 $880,121 483,583
2024-06-30 $802,747 483,583
2024-03-31 $1,107,405 483,583
2023-12-31 $935,797 472,625
2023-09-30 $614,412 472,625
2023-06-30 $765,652 472,625
2023-03-31 $1,006,691 472,625
2022-12-31 $1,563,712 422,625